Meet Our Leadership Team
Aaron Carman, PhD | Director
Kirstie Stansfield, PhD | Chief Operating Officer
Kirstie Stansfield, PhD | Chief Operating Officer
In 2015, Aaron became ICR's founding director and continues in that role, leading ICR's scientific programs and growing staff of 25 full-time scientists. A native Kansan, Aaron is an undergraduate alumnus of K-State and earned his doctorate in Molecular Genetics and Neuroscience from the University of Texas, Houston. He received postdoct
In 2015, Aaron became ICR's founding director and continues in that role, leading ICR's scientific programs and growing staff of 25 full-time scientists. A native Kansan, Aaron is an undergraduate alumnus of K-State and earned his doctorate in Molecular Genetics and Neuroscience from the University of Texas, Houston. He received postdoctoral training in neurophysiology and molecular neurodegeneration at Cornell University and Memorial Sloan-Kettering Cancer Center before joining the Alzheimer's Drug Discovery Foundation. Aaron helped build ADDF's Aging and Alzheimer's Prevention Program and its cornerstone website CognitiveVitality. He lives in New Jersey with his wife and two children.
Kirstie Stansfield, PhD | Chief Operating Officer
Kirstie Stansfield, PhD | Chief Operating Officer
Kirstie Stansfield, PhD | Chief Operating Officer
Dr. Kirstie Stansfield is Chief Operating Officer and Principal Scientist at InVitro Cell Research (ICR), leading the Translational Neuroregeneration Program. With over 15 years of experience in neuroscience research, Dr. Stansfield spearheads ICR's efforts to develop innovative stem cell therapies for cognitive aging, neuronal repair, a
Dr. Kirstie Stansfield is Chief Operating Officer and Principal Scientist at InVitro Cell Research (ICR), leading the Translational Neuroregeneration Program. With over 15 years of experience in neuroscience research, Dr. Stansfield spearheads ICR's efforts to develop innovative stem cell therapies for cognitive aging, neuronal repair, and age-related dementia prevention. Dr. Stansfield earned her Ph.D. in Neuroscience from the University of South Florida, following her undergraduate studies in Psychology at UNC Greensboro. Her postdoctoral work at Johns Hopkins and Columbia Universities focused on neurotoxins' molecular and behavioral impacts on the developing brain. She later continued her research as a Research Faculty member at Columbia University. She has instructed numerous undergraduate and graduate courses throughout her career. Before joining ICR in 2018, Dr. Stansfield gained valuable industry experience as a Medical Science Liaison with Eli Lilly, specializing in neurodegeneration/ Alzheimer's Disease. This unique combination of academic research and pharmaceutical expertise allows her to bridge the gap between scientific discovery and clinical application in her current role at ICR. As COO, Dr. Stansfield oversees ICR's day-to-day operations while driving the company's scientific strategy and research initiatives. Her leadership has been instrumental in advancing ICR's stem cell technologies and translating promising discoveries into potential therapeutic interventions for age-related cognitive decline.
Around ICR
Members of our In Vitro Diagnostics and Biomarkers Team are hard at work. This is just one of our actual research areas of our over 10,000 sq ft of lab and office space.
Our Molecular Biology lab plays a central role in our regenerative medicine research.
Robotic liquid handling is just one of the ways we accelerate our research into ways to fight aging and age-related disease.